Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:(%22Essai clinique phase I%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 829768

  • Page / 33191
Export

Selection :

  • and

Une stèle inédite du Sérapéum mentionnant le nom de Sheshonq Ier = An unpublished stela from the Serapeum mentioning Sheshonq I nameALY, M. I.Bulletin de la Société d'égyptologie. 1996, Num 20, pp 5-16, issn 0255-6286Article

Les ellipticines et aza-ellipticines = Ellipticins and aza-ellipticinsGISSELBRECHT, C; MARTY, M; MIGNOT, L et al.Actualités hématologiques. 1984, Vol 18, pp 193-207, issn 0567-8757Article

Characterization and multiparameter analysis of visual adverse events in Irofulven single-agent Phase I and II trialsRAYMOND, Eric; KAHATT, Carmen; CULLEN, Michael et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7566-7574, issn 1078-0432, 9 p.Article

Clinical development of anticancer agents. A National Cancer Institute perspective = Développement de l'utilisation clinique de substances anticancéreuses. Une perspective du National Cancer InstituteMARSONI, S; WITTES, R.Cancer treatment reports. 1984, Vol 68, Num 1, pp 77-85, issn 0361-5960Article

Why was David disqualified as temple builder ? The meaning of 1 Chronicles 22.8DIRKSEN, P. B.Journal for the study of the Old Testament. 1996, Num 70, pp 51-56, issn 0309-0892Article

The best guess approach to phase I trial designROSA, Daniela D; HARRIS, John; JAYSON, Gordon C et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 206-208, issn 0732-183X, 3 p.Article

TCNU: a ray of hope for designer nitrosoureas?WORKMAN, P.European journal of cancer & clinical oncology. 1987, Vol 23, Num 12, pp 1823-1828, issn 0277-5379Article

CLINICAL TRIALSOF NEW DRUGS.DOLLERY CT; WADE OL; TURNER P et al.1977; J. R. COLL. PHYSICIANS LONDON; G.B.; DA. 1977; VOL. 11; NO 3; PP. 226-233; BIBL. 1 REF.Article

Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC#4366650 and cryopreserved autologous marrow transplantation for retractory cancer: a phase I-II study = BCNU à haute dose et greffe autologue de moelle cryocongelée dans les tumeurs résistantes. Une étude phase I-IIPHILLIPS, G. L; FAY, J. W; HERZIG, G. P et al.Cancer. 1983, Vol 52, Num 10, pp 1792-1802, issn 0008-543XArticle

Méthodologie des essais cliniques en cancérologie : médicaments anticancéreux (2e partie) = Design of clinical trials in oncologyTRANCHAND, Brigitte; CHABAUD, Sylvie; COLOMBAN, Olivier et al.La Lettre du pharmacologue (Boulogne). 2008, Vol 22, Num 3, pp 98-110, issn 0984-452X, 13 p.Article

Early clinical trials of mitoxantrone = Premiers essais cliniques de la mitoxantroneBODEY, G. P; VALDIVIESO, M; HWEE-YONG YAP et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 103-114, issn 0146-0447Article

Phase I research and the meaning of direct benefitROSS, Lainie.The Journal of pediatrics. 2006, Vol 149, Num 1, issn 0022-3476, S20-S24, SUP1Conference Paper

BIOLOGIC RESPONSE-MODIFYING AGENTS: WHAT IS AN APPROPRIATE PHASE I-II STRATEGY.CARTER SK.1980; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1980; VOL. 8; NO 4; PP. 207-210; BIBL. 4 REF.Article

Transposition de la Directive Essais Cliniques: Recommandations sur le contenu d'un dossier de demande d'autorisation pour les premiers essais chez l'homme = Transposition of the clinical trial directive : recommandations on the contents of a dossier for the request for authorisation of the first trials in human subjectsBELORGEY, Chantal; PLETAN, Yannick; GOEHRS, Jean-Marie et al.Thérapie (Paris). 2004, Vol 59, Num 3, pp 329-336, issn 0040-5957, 8 p.Conference Paper

90-Days mortality rate in patients treated within the context of a phase-I trial : How should we identify patients who should not go on trial?ARKENAU, Hendrik-Tobias; OLMOS, David; JOO ERN ANG et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1536-1540, issn 0959-8049, 5 p.Article

Comment faire évoluer le paradigme du développement clinique et son découpage en phases I, II, IIIBAMBERGER, Marion; MOORE, Nicholas; LECHAT, Philippe et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 327-330, issn 0040-5957, 4 p.Article

CLINICAL TRIALS IN CANCER CHEMOTHERAPY.CARTER SK.1977; CANCER; U.S.A.; DA. 1977; VOL. 40; NO 1, SUPPL.; PP. 544-557; BIBL. 1 P. 1/2Article

MANAGEMENT OF TRIALS IN THE DEVELOPMENT OF CANCER CHEMOTHERAPY.WILLIAMS CJ; CARTER SK.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 434-447; BIBL. 24 REF.Article

Les essais cliniques = Clinical trialsZIVIN, J.Pour la science. 2000, Num 272, pp 100-105, issn 0153-4092Article

Proceedings/Symposium on the development of a drug, LHRH agonists: 3rd. international congress of andrology, Boston MA, April 27-May 2, 1985VICKERY, B. H.Journal of andrology. 1987, Vol 8, Num 1, pp S.1-S.31, issn 0196-3635Conference Proceedings

Peplomycin and liblomycin, a new analogues of bleomycinTAKITA, T; OGINO, T.Biomedicine & pharmacotherapy. 1987, Vol 41, Num 5, pp 219-226, issn 0753-3322Article

Phase I and II agents in cancer therapy. I: Anthracyclines and related compoundsWADLER, S; FUKS, J. Z; WIERNIK, P. H et al.Journal of clinical pharmacology. 1986, Vol 26, Num 7, pp 491-509, issn 0091-2700Article

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissueFORMENTI, Silvia C; GIDEA-ADDEO, Daniela; GOLDBERG, Judith D et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2236-2242, issn 0732-183X, 7 p.Article

Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USASAUSVILLE, E. A; FEIGAL, E.Annals of oncology. 1999, Vol 10, Num 11, pp 1287-1291, issn 0923-7534Article

Recherche de la dose optimale des antithrombotiques = Determining the optimal dose of anti-thrombotic agentsMISMETTI, P; LAPORTE-SIMITSIDIS, S; DECOUSUS, H et al.Archives des maladies du coeur et des vaisseaux. 1996, Vol 89, Num 11, pp 1473-1477, issn 0003-9683, SUPArticle

  • Page / 33191